TerrAscend Résultats passés
Passé contrôle des critères 0/6
TerrAscend a connu une croissance annuelle moyenne de ses bénéfices de 16.9%, tandis que le secteur Pharmaceuticals a vu ses bénéfices augmenter de en hausse à 19.2% par an. Les revenus ont augmenté de en hausse à un taux moyen de 8.7% par an.
Informations clés
16.88%
Taux de croissance des bénéfices
26.18%
Taux de croissance du BPA
| Pharmaceuticals Croissance de l'industrie | 23.06% |
| Taux de croissance des recettes | 8.73% |
| Rendement des fonds propres | -26.01% |
| Marge nette | -10.81% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour du récit • Jul 02
TSND: Uplisting Preparations And New Jersey Dispensary Deal Will Support Upside
Analysts have lifted their CA$ price target on TerrAscend, reflecting a revised fair value estimate of CA$1.50. This figure is supported by updated assumptions for revenue growth, profit margins, and future P/E levels.
Mise à jour du récit • Jun 18
TSND: Expanding M&A Pipeline And New Leadership Will Support Future Profitability
Analysts have nudged their fair value price target for TerrAscend to CA$2.01. This reflects updated assumptions for discount rate, revenue growth, profit margin and future P/E that slightly adjust how they frame the stock’s risk and earnings potential.Mise à jour du récit • Jun 03
TSND: Active M&A Agenda And Margin Improvements Will Support Future Profitability
Analysts have adjusted their TerrAscend price target to CA$2.01 from CA$2.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend reiterated an active M&A agenda, with executives highlighting ongoing discussions for accretive acquisitions and interest in distressed assets in core markets, sourced from the first quarter 2026 results call.Mise à jour du récit • May 07
TSND: Expanded Retail Footprint And Margin Gains Will Support Future Profitability
Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from CA$2.00, citing updated assumptions around revenue growth, profit margins and a lower future P/E multiple that together support a modestly improved valuation outlook. What's in the News TerrAscend issued earnings guidance for the first quarter of 2026, anticipating net revenue of $65.5 million, compared with $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025 (Key Developments).Mise à jour du récit • Apr 18
TSND: New CFO Hire And Share Buyback Will Support Future Upside
Analysts have modestly adjusted their price target on TerrAscend, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Together, these factors refine their view of what the shares could be worth in CA$ terms.Mise à jour du récit • Apr 04
TSND: New Brand Partnership And Share Buyback Will Support Future Upside
Analysts have nudged their TerrAscend price target modestly higher to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend announced the official launch of TYSON 2.0 products in Pennsylvania and Maryland, covering premium flower and high potency vape products under its exclusive partnership with the brand (Key Developments).Mise à jour du récit • Mar 20
TSND: Expanded New Jersey Retail Footprint Will Support Future Profitability
Analysts have slightly adjusted their CA$ price target on TerrAscend, citing updated assumptions for revenue growth, profit margins, and a modest change in the expected future P/E multiple. What's in the News TerrAscend completed a share buyback tranche between October 1, 2025 and December 31, 2025, repurchasing 75,000 shares for $0.03m, equal to 0.02% of shares under the program first announced on August 20, 2025 (Key Developments).Mise à jour du récit • Mar 04
TSND: Expanded New Jersey Footprint Will Support Future Profitability
Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from about CA$1.98, citing updated assumptions that include a modestly adjusted discount rate, changes to revenue growth and profit margin expectations, and a higher future P/E estimate. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey.Mise à jour du récit • Feb 18
TSND: Union Chill Expansion Will Support Future Retail Scale And Margins
Analysts have trimmed their CA$ price target for TerrAscend, citing a slightly higher discount rate, a modestly reduced revenue outlook, and an improved profit margin profile that together reset expectations around the stock's future P/E level. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing Hunterdon County dispensary and bringing TerrAscend's New Jersey retail footprint to four locations (Key Developments).Article d’analyse • Feb 12
More Unpleasant Surprises Could Be In Store For TerrAscend Corp.'s (TSE:TSND) Shares After Tumbling 27%
TerrAscend Corp. ( TSE:TSND ) shares have had a horrible month, losing 27% after a relatively good period beforehand...Mise à jour du récit • Feb 04
TSND: Union Chill Deal Will Drive Future Retail And Margin Upside
Analysts have trimmed their price target on TerrAscend to about US$1.25 from roughly US$1.50, citing reduced revenue growth expectations and a lower future P/E multiple, partly offset by higher projected profit margins. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County, New Jersey, and bringing its retail footprint in the state to four dispensaries (Key Developments).Mise à jour du récit • Jan 21
TSND: Expanded Retail Footprint And Licensing Will Support Future Profitability
Analysts have modestly revised their price target on TerrAscend, citing slightly firmer profit margin expectations and a small adjustment to revenue trends and future P/E assumptions. Together, these factors support a refined fair value estimate without a material change in the overall valuation level.Mise à jour du récit • Jan 06
TSND: Expanded Mid Atlantic Footprint And Licensing Will Support Higher Profitability
Analysts have nudged their price target on TerrAscend toward about $2.00, reflecting updated views that incorporate higher projected profit margins, a lower assumed future P/E multiple near 43, and adjusted revenue expectations. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County and bringing TerrAscend's New Jersey retail footprint to four dispensaries (Key Developments).Mise à jour du récit • Dec 15
TSND: Licensing Expansion Into Mid Atlantic Markets Will Drive Stronger Profitability
Analysts have raised their price target on TerrAscend by approximately $2.25 to about $1.98 per share. They cited expectations for stronger profit margins and a more reasonable future earnings multiple, even as they moderate revenue growth assumptions and apply a slightly higher discount rate.Article d’analyse • Dec 14
TerrAscend Corp.'s (TSE:TSND) Shares Climb 123% But Its Business Is Yet to Catch Up
TerrAscend Corp. ( TSE:TSND ) shares have had a really impressive month, gaining 123% after a shaky period beforehand...Article d’analyse • Nov 09
Earnings Release: Here's Why Analysts Cut Their TerrAscend Corp. (TSE:TSND) Price Target To CA$1.75
TerrAscend Corp. ( TSE:TSND ) shareholders are probably feeling a little disappointed, since its shares fell 4.0% to...Article d’analyse • Oct 30
TerrAscend Corp.'s (TSE:TSND) 27% Share Price Plunge Could Signal Some Risk
The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 27% over the previous 30 days, handing back...Article d’analyse • Jun 11
Some TerrAscend Corp. (TSE:TSND) Shareholders Look For Exit As Shares Take 34% Pounding
Unfortunately for some shareholders, the TerrAscend Corp. ( TSE:TSND ) share price has dived 34% in the last thirty...Article d’analyse • Apr 27
TerrAscend Corp. (TSE:TSND) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely
The TerrAscend Corp. ( TSE:TSND ) share price has fared very poorly over the last month, falling by a substantial 30...
Nouveau récit • Apr 02
ERP Implementation And Ohio Expansion Will Improve Operational Efficiency
Strategic expansions into new markets like Ohio and New Jersey are poised to enhance revenue and profitability through streamlined operations and vertical integration.Article d’analyse • Mar 05
With A 29% Price Drop For TerrAscend Corp. (TSE:TSND) You'll Still Get What You Pay For
To the annoyance of some shareholders, TerrAscend Corp. ( TSE:TSND ) shares are down a considerable 29% in the last...Article d’analyse • Jan 03
These 4 Measures Indicate That TerrAscend (TSE:TSND) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d’analyse • Sep 03
Is TerrAscend (TSE:TSND) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d’analyse • Apr 25
TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Article d’analyse • Mar 10
What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash
The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 25% over the previous 30 days, handing back...Article d’analyse • Jan 24
Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%
TerrAscend Corp. ( TSE:TSND ) shareholders would be excited to see that the share price has had a great month, posting...Article d’analyse • Dec 25
Is TerrAscend (TSE:TSND) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Aug 13
TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Jul 03
TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors
When close to half the companies in the Pharmaceuticals industry in Canada have price-to-sales ratios (or "P/S") below...Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment TerrAscend gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 262 | -28 | 87 | 0 |
| 31 Dec 25 | 261 | -29 | 86 | 0 |
| 30 Sep 25 | 299 | -71 | 107 | 0 |
| 30 Jun 25 | 300 | -77 | 110 | 0 |
| 31 Mar 25 | 263 | -26 | 91 | 0 |
| 31 Dec 24 | 268 | -28 | 91 | 0 |
| 30 Sep 24 | 288 | -81 | 96 | 0 |
| 30 Jun 24 | 312 | -74 | 101 | 0 |
| 31 Mar 24 | 317 | -81 | 109 | 0 |
| 31 Dec 23 | 251 | -36 | 84 | 0 |
| 30 Sep 23 | 300 | -50 | 121 | 0 |
| 30 Jun 23 | 277 | -342 | 119 | 0 |
| 31 Mar 23 | 269 | -311 | 122 | 0 |
| 31 Dec 22 | 248 | -304 | 116 | 0 |
| 30 Sep 22 | 212 | -298 | 94 | 0 |
| 30 Jun 22 | 195 | 59 | 88 | 0 |
| 31 Mar 22 | 189 | 13 | 76 | 0 |
| 31 Dec 21 | 194 | 13 | 75 | 0 |
| 30 Sep 21 | 211 | -96 | 88 | 0 |
| 30 Jun 21 | 200 | -165 | 80 | 0 |
| 31 Mar 21 | 175 | -144 | 73 | 0 |
| 31 Dec 20 | 132 | -125 | 61 | 0 |
| 30 Sep 20 | 118 | -159 | 54 | 1 |
| 30 Jun 20 | 99 | -156 | 55 | 1 |
| 31 Mar 20 | 75 | -155 | 49 | 1 |
| 31 Dec 19 | 64 | -161 | 46 | 1 |
| 30 Sep 19 | 48 | -44 | 41 | 0 |
| 30 Jun 19 | 30 | -33 | 32 | 0 |
| 31 Mar 19 | 16 | -23 | 25 | 0 |
| 31 Dec 18 | 5 | -16 | 17 | 0 |
| 30 Sep 18 | 1 | -9 | 12 | 0 |
| 30 Jun 18 | 0 | -8 | 7 | 0 |
| 31 Mar 18 | 0 | -7 | 6 | 0 |
| 31 Dec 17 | 0 | -5 | 5 | 0 |
| 30 Sep 17 | 0 | -5 | 4 | 0 |
| 30 Jun 17 | 0 | -4 | 3 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
Des revenus de qualité: TSND n'est actuellement pas rentable.
Augmentation de la marge bénéficiaire: TSND n'est actuellement pas rentable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: TSND n'est pas rentable, mais a réduit ses pertes au cours des 5 dernières années à un taux de 16.9% par an.
Accélération de la croissance: Impossible de comparer la croissance des bénéfices de TSND au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable
Bénéfices par rapport au secteur d'activité: TSND n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Pharmaceuticals ( 96.7% ).
Rendement des fonds propres
ROE élevé: TSND a un retour sur capitaux propres négatif ( -26.01% ), car il n'est actuellement pas rentable.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/07/05 06:29 |
| Cours de l'action en fin de journée | 2026/07/03 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d'analyse utilisé pour générer ce rapport sont disponibles sur notre page Github, nous proposons également des guides pour apprendre à utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
TerrAscend Corp. est couverte par 9 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Matt Bottomley | Canaccord Genuity |
| Shaan Mir | Canaccord Genuity |